On 12 August 2019, Shanghai Stock Exchange Sci-Tech innovation board (also called STAR Market) welcomed stock symbol: 688321, Shenzhen Chipscreen Biosciences Co., Ltd (hereinafter referred to as Chipscreen Biosciences), the first innovative medical enterprise to list on the STAR Market. As the issuer's counsel, Llinks provided legal services during the listing of Chipscreen Biosciences, harnessing Llinks solid professional competence and rich practical experience in the capital market and healthcare industry.
Chipscreen Biosciences is a leading biopharmaceutical enterprise that aims to develop innovative medicines with an integrated supply chain, from drug discovery, drug development and industrialization to sales. Its independent research and development of innovative medicines have achieved major breakthroughs.
Llinks technology innovation legal service business: relying on the advantages of its integrated platform, all Llinks professionals have set up cross-field professional legal service teams to serve science and innovation enterprises, investment institutions, asset management institutions, investment banks and financial institutions. We work with our partners, HR department and other professionals to share the most interesting topics in the field of science and technology related to securities, equity investment and M&A, asset management, dispute resolution and risk prevention, compliance and information security, intellectual property rights, equity incentives. Llinks is committed to provide clients with cutting edge legal service with the firm's devotion, creativity and ability to respond rapidly.
